AccessPak for HIV PEP Expanded with Kaletra and Skyrizi (150 MG Dose)
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Skyrizi (150 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Skyrizi, Skyrizi topical
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Skyrizi Injection
- AccessPak for HIV PEP Expanded with Kaletra-Skyrizi topical
- AccessPak for HIV PEP Expanded with Kaletra-Sleep Aid
- AccessPak for HIV PEP Expanded with Kaletra-Sleep Aid Tablets
- AccessPak for HIV PEP Expanded with Kaletra-Sleepinal
- AccessPak for HIV PEP Expanded with Kaletra-Slo-Niacin
- Skyrizi (150 MG Dose)-AccessPak for HIV PEP Expanded with Viracept
- Skyrizi (150 MG Dose)-Accolate
- Skyrizi (150 MG Dose)-Accretropin
- Skyrizi (150 MG Dose)-Accucaine
- Skyrizi (150 MG Dose)-AccuHist Drops
- Skyrizi (150 MG Dose)-AccuHist PDX Drops